Literature DB >> 17938192

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.

Aspasia Katragkou1, Athanasios Chatzimoschou, Maria Simitsopoulou, Maria Dalakiouridou, Eudoxia Diza-Mataftsi, Chaido Tsantali, Emmanuel Roilides.   

Abstract

The activities of voriconazole, posaconazole, caspofungin, and anidulafungin against Candida albicans and Candida parapsilosis biofilms were evaluated. In contrast to planktonic cells, the MICs for voriconazole and posaconazole for the biofilms of the two species were high (>or=256 and >64 mg/liter, respectively) but relatively low for the echinocandins caspofungin and anidulafungin (<or=1 and <or=2 mg/liter, respectively).

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17938192      PMCID： PMC2223899          DOI： 10.1128/AAC.00856-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Candida biofilms and their susceptibility to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 2.  Intravascular-catheter-related infections.

Authors:  I Raad
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

3.  Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.

Authors:  S P Hawser; H Norris; C J Jessup; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

6.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

7.  Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.

Authors:  Georgios Chamilos; Russell E Lewis; Nathaniel Albert; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

8.  Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors:  D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.

Authors:  David A Stevens; Marife Espiritu; Rachana Parmar
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Authors:  Luis Ostrosky-Zeichner; John H Rex; Peter G Pappas; Richard J Hamill; Robert A Larsen; Harold W Horowitz; William G Powderly; Newton Hyslop; Carol A Kauffman; John Cleary; Julie E Mangino; Jeannette Lee
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191
View more
  45 in total

1.  In vitro activity of anidulafungin against Candida albicans biofilms.

Authors:  Melissa J Jacobson; Kerryl E Piper; Gary Nguyen; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

2.  In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.

Authors:  Barbara Fiori; Brunella Posteraro; Riccardo Torelli; Mario Tumbarello; David S Perlin; Giovanni Fadda; Maurizio Sanguinetti
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  Favorable outcome of neonatal cerebrospinal fluid shunt-associated Candida meningitis with caspofungin.

Authors:  Jop Jans; Roger J M Brüggemann; V Christmann; Paul E Verweij; Adilia Warris
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

4.  Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.

Authors:  Athanasios Chatzimoschou; Aspasia Katragkou; Maria Simitsopoulou; Charalampos Antachopoulos; Elpiniki Georgiadou; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms.

Authors:  Nermin H Ibrahim; Nahla A Melake; Ali M Somily; Azza S Zakaria; Manal M Baddour; Amany Z Mahmoud
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

Review 6.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

Review 8.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 9.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

10.  Fungal echinocandin resistance.

Authors:  Louise A Walker; Neil A R Gow; Carol A Munro
Journal:  Fungal Genet Biol       Date:  2009-09-19       Impact factor: 3.495
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.